USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 12, 2021 (est) | Sep 30, 2021 | - | $-0.73 | $-0.32 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 12, 2021 (est) | Sep 30, 2021 | - | $0.00 | $0.00 |
Calliditas Therapeutics Ab (Publ)'s next estimated earnings date (based on same quarter last year's date) is Nov 12, 2021 for the fiscal quarter ending Sep 30, 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $-0.61 | $-0.90 | $-0.39 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $-1.74 | $-3.26 | $-0.97 |
| Dec 2022 | 4 | $-0.55 | $-1.48 | $0.64 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.61 | $-0.58 | $-0.58 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-1.74 | $-1.67 | $-1.68 |
| Dec 2022 | 0 / 0 | $-0.53 | $-0.59 | $-0.59 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $590.00K | $0.00 | $1.76M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $590.00K | $0.00 | $1.76M |
| Dec 2022 | 3 | $89.25M | $27.00M | $159.58M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Aug 19, 2021 | Jun 2021 | $-0.48 | $-0.73 | -51.11% |
| May 18, 2021 | Mar 2021 | $-0.45 | $-0.60 | -35.21% |
| Feb 18, 2021 | Dec 2020 | $-0.45 | $-0.41 | 9.11% |
| Nov 12, 2020 | Sep 2020 | $-0.26 | $-0.32 | -23.12% |
| Aug 13, 2020 | Jun 2020 | $-0.30 | $-0.17 | 42.37% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Feb 18, 2021 | Dec 2020 | $-1.25 | $-0.90 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Aug 19, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 18, 2021 | Mar 2021 | $10.00K | $0.00 | - |
| Feb 18, 2021 | Dec 2020 | $0.00 | $400.00K | - |
| Nov 12, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 13, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Feb 18, 2021 | Dec 2020 | $50.00K | $874.00K | 1648.00% |
CALT's next estimated earnings date (based on same quarter last year's report date) is Nov 12, 2021 for the fiscal quarter ending Sep 30, 2021.
Calliditas Therapeutics Ab (Publ)'s previous earnings date was Aug 19, 2021 for its fiscal quarter ended Jun 30, 2021.
CALT's earnings per share (EPS) was $-0.73, missing the consensus analysts forecast of $-0.48 by -51.11%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 20.79%, and lower than the same period a year before (Jun 2020) by 320.65%.
Revenues were $0.00.
The company reported a net income of $-159.84M.Free cash flow for the quarter was $-132.91M , compared to $-134.18M last quarter and $-67.02M a year before.
Calliditas Therapeutics Ab (Publ)'s previous annual earnings date was Feb 18, 2021 for its fiscal year ended Dec 31, 2020.
CALT's earnings per share (EPS) was $-0.90.
Revenues were $874.00K, better than the forecast of $50.00K by 1648.00%, and down by -99.53% from previous year's revenue.
The company reported a net income of $-433.49M.
Calliditas Therapeutics Ab (Publ) reported a free cash flow of $-309.18M for its fiscal year, compared to $-87.19M a year ago.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.